Prescribers' compliance with summary of product characteristics of dabigatran, rivaroxaban and apixaban-A European comparative drug utilization study.
Rottenkolber M, Schmiedl S, Ibánez L, Sabaté M, Ballarín E, Vidal X, Leon-Muñoz LM, Huerta C, Martin Merino E, Montero D, Gasse C, Andersen M, Aakjaer M, De Bruin ML, Gerlach R, Tauscher M, Souverein PC, van den Ham R, Klungel O, Gardarsdottir H; PE&PV consortium.
Rottenkolber M, et al. Among authors: ibanez l.
Basic Clin Pharmacol Toxicol. 2021 Mar;128(3):440-454. doi: 10.1111/bcpt.13517. Epub 2020 Nov 2.
Basic Clin Pharmacol Toxicol. 2021.
PMID: 33037766
Free article.